Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Deals
Features
News
Region
Sectors
Size
Uncategorised

Europe

UCL tees up second Technology Fund
UCL Technology Fund 2 has achieved a first close on the way to its $131m target, with a cornerstone investment from UCL itself.
Daily deal net: July 31, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Daily deal net: July 30, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Bright Peak ascends to $35m series A
Drug protein discovery company Bright Peak hopes to deliver conjugated cancer immunotherapies based on an ETH Zürich-invented platform.
Enthera enters $32.8m series A round
Enthera Pharmaceuticals was co-founded by faculty from University of Milan and is using stem cells to treat autoimmune disorders.
CureVac files for IPO
CureVac has filed for an initial public offering in the US, 20 years after being spun out of Eberhard Karls University of Tübingen.
Indigo Diabetes stabilises $44.5m
Indigo Diabetes increased its total funding to $52.6m with a series B round backed by Imec.xpand and returning investor Qbic.
Daily deal net: July 27, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Other News

Tubulis bursts $12.5m
Tubulis has raised series A funding to progress an ADC development platform invented at Leibniz Research Institute and Ludwig Maximillians University.
Frontier IP taps fresh funds
Frontier IP attracted $2.9m in a placement that will support its portfolio in responding to coronavirus-related challenges or opportunities.
CureVac completes $640m round
Tübingen's messenger RNA vaccine and drug developer's latest round includes a $171m investment by strategic partner GlaxoSmithKline.
Scalable Capital mounts $58m series D campaign
Scalable Capital is valued in excess of $460m following a round that lifted the digital wealth manager's total funding to about $130m.
Daily deal net: July 22, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
T3 Pharma treats itself to more funding
Boehringer Ingelheim Venture Fund followed an investment last September by contributing to a $26.8m round for the Basel spinout.

Editor's Picks

SETsquared: a global leader continues charging ahead
The world’s number one incubator has been making a big impact since 2002, having supported more than 4,000 entrepreneurs that have raised more than $2.2bn between them.
Feeding the world: the story of Cellular Agriculture
Cellular Agriculture was spun out of University of Bath in 2016 as the UK’s first startup in the cultured meat space, but its ambitions go far beyond a lab-grown burger.
Big deal: Oxford PV begins capturing series D
Goldwind, Legal & General and Equinor have all taken part in a series D that achieved a $41m first close and boosted the Oxford spinout’s total equity and debt to more than $118m.
Otsuka takes up Veryan’s acquisition offer
ICL vascular implant spinout Veryan Medical has been bought by medical device firm Otsuka after raising $56m from investors including IP Group.
test reg

Login